Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events

Journal of Cardiovascular Magnetic Resonance

Volumn 11, Issue 1, 2009, Pages

  Mani, V ^a   Muntner, Paul ^a   Gidding, Samuel S ^b   Aguiar, Silvia H ^a   Aidi, Hamza El ^a   Weinshelbaum, Karen B ^a   Taniguchi, Hiroaki ^a   Van Der Geest, Rob ^c   Reiber, Johan H C ^c   Bansilal, Sameer ^a   Farkouh, Michael ^a   Fuster, Valentin ^a   Postley, John E ^d   Woodward, Mark ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; THICKNESS; THORACIC AORTA; AORTA DISEASE; AREA UNDER THE CURVE; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

AGED; AORTA, THORACIC; AORTIC DISEASES; AREA UNDER CURVE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RISK FACTORS;

EID: 67049119150     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-11-10     Document Type: Article

References (42)

1. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al.: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation 2003, 108:1772-1778. (Pubitemid 37296082)
2. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, et al.: From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I. Circulation 2003, 108:1664-1672. (Pubitemid 37243650)
3. Gonzalez ER, Kannewurf BS: Atherosclerosis: a unifying disorder with diverse manifestations. Am J Health Syst Pharm 1998, 55:S4-7.
4. Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy JP, Maunoury C, Hugonnet F, Sauvaget E, Trinquart L, Faraggi M: Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008, 15:209-217.
5. Bamberg F, Dannemann N, Shapiro MD, Seneviratne SK, Ferencik M, Butler J, Koenig W, Nasir K, Cury RC, Tawakol A, et al.: Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography. Arterioscler Thromb Vasc Biol 2008, 28:568-574.
6. Feinstein SB, Voci P, Pizzuto F: Noninvasive surrogate markers of atherosclerosis. Am J Cardiol 2002, 89:31C-43C. discussion 43C-44C (Pubitemid 34251289)
7. Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T, Turan Sezgin A, Muderrisoglu H: Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography 2006, 23:835-842. (Pubitemid 44630156)
8. Crouse JR, Byington RP, Bond MG, Espeland MA, Sprinkle JW, McGovern M, Furberg CD: Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome. Control Clin Trials 1992, 13:495-506. (Pubitemid 23001797)
9. Gorter PM, Visseren FL, Algra A, Graaf Y van der: The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study. Diabet Med 2007, 24:1352-1360. (Pubitemid 350179454)
10. Gorter PM, Olijhoek JK, Graaf Y van der, Algra A, Rabelink TJ, Visseren FL: Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 2004, 173:363-369. (Pubitemid 38469808)
11. Hatsukami TS, Ross R, Polissar NL, Yuan C: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000, 102:959-964. (Pubitemid 30656003)
12. Trivedi RA, JM UK-I, Graves MJ, Horsley J, Goddard M, Kirkpatrick PJ, Gillard JH: MRI-derived measurements of fibrous-cap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 2004, 46:738-743. (Pubitemid 39294893)
13. Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, Small R, Davies JW, Kerwin WS, Hatsukami TS: In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001, 104:2051-2056. (Pubitemid 33027045)
14. Mohler ER 3rd, Sarov-Blat L, Shi Y, Hamamdzic D, Zalewski A, Macphee C, Llano R, Pelchovitz D, Mainigi SK, Osman H, et al.: Site- Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature. Arterioscler Thromb Vasc Biol 2008. (Pubitemid 351544098)
15. Kardys I, Vliegenthart R, Oudkerk M, Hofman A, Witteman JC: The female advantage in cardiovascular disease: do vascular beds contribute equally? Am J Epidemiol 2007, 166:403-412. (Pubitemid 47216799)
16. Sutton-Tyrrell K, Kuller LH, Matthews KA, Holubkov R, Patel A, Edmundowicz D, Newman A: Subclinical atherosclerosis in multiple vascular beds: an index of atherosclerotic burden evaluated in postmenopausal women. Atherosclerosis 2002, 160:407-416. (Pubitemid 34159335)
17. Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, et al.: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431-1443.
18. Brown BG, Taylor AJ: Does ENHANCE diminish confidence in lowering LDL or in ezetimibe? N Engl J Med 2008, 358:1504-1507.
19. Drazen JM, Jarcho JA, Morrissey S, Curfman GD: Cholesterol lowering and ezetimibe. N Engl J Med 2008, 358:1507-1508.
20. Mani V, Itskovich VV, Aguiar SH, Mizsei G, Aguinaldo JG, Samber DD, Macaluso FM, Fayad ZA: Comparison of gated and non-gated fast multislice black-blood carotid imaging using rapid extended coverage and inflow/outflow saturation techniques. J Magn Reson Imaging 2005, 22:628-633. (Pubitemid 41572714)
21. Mani V, Itskovich VV, Szimtenings M, Aguinaldo JG, Samber DD, Mizsei G, Fayad ZA: Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging. Radiology 2004, 232:281-288. (Pubitemid 38787850)
22. Yuan C, Kerwin WS, Yarnykh VL, Cai J, Saam T, Chu B, Takaya N, Ferguson MS, Underhill H, Xu D, et al.: MRI of atherosclerosis in clinical trials. NMR Biomed 2006, 19:636-654. (Pubitemid 44515609)
23. Wasserman BA, Sharrett AR, Lai S, Gomes AS, Cushman M, Folsom AR, Bild DE, Kronmal RA, Sinha S, Bluemke DA: Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke 2008, 39:329-335. (Pubitemid 351619451)
24. Saam T, Hatsukami TS, Yarnykh VL, Hayes CE, Underhill H, Chu B, Takaya N, Cai J, Kerwin WS, Xu D, et al.: Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging 2007, 26:344-352. (Pubitemid 47257733)
25. Takaya N, Cai J, Ferguson MS, Yarnykh VL, Chu B, Saam T, Polissar NL, Sherwood J, Cury RC, Anders RJ, et al.: Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging 2006, 24:203-210.
26. Saam T, Kerwin WS, Chu B, Cai J, Kampschulte A, Hatsukami TS, Zhao XQ, Polissar NL, Neradilek B, Yarnykh VL, et al.: Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 2005, 7:799-808. (Pubitemid 41770058)
27. Touze E, Toussaint JF, Coste J, Schmitt E, Bonneville F, Vandermarcq P, Gauvrit JY, Douvrin F, Meder JF, Mas JL, Oppenheim C: Reproducibility of high-resolution MRI for the identification and the quantification of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke 2007, 38:1812-1819. (Pubitemid 46847252)
28. Geest RJ van der, Reiber JH: Quantification in cardiac MRI. J Magn Reson Imaging 1999, 10:602-608.
29. Kerwin W, Xu D, Liu F, Saam T, Underhill H, Takaya N, Chu B, Hatsukami T, Yuan C: Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging 2007, 18:371-378. (Pubitemid 350145117)
30. Saam T, Yuan C, Chu B, Takaya N, Underhill H, Cai J, Tran N, Polissar NL, Neradilek B, Jarvik GP, et al.: Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 2007, 194:e34-42. (Pubitemid 47513067)
31. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
32. Riccioni G, De Santis A, Cerasa V, Menna V, Di Ilio C, Schiavone C, Ballone E, D'Orazio N: Atherosclerotic plaque formation and risk factors. Int J Immunopathol Pharmacol 2003, 16:25-31. (Pubitemid 36268137)
33. Romero JR: Prevention of ischemic stroke: overview of traditional risk factors. Curr Drug Targets 2007, 8:794-801. (Pubitemid 47163389)
34. Morka J, Krzeminska-Pakula M, Drozdz J, Morka A: Factors affecting the progression of atherosclerosis in the coronary arteries. Kardiol Pol 2007, 65:1307-1311. (Pubitemid 350164185)
35. Sobel BE: Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med 2007, 120:S3-11. (Pubitemid 47361037)
36. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371-1375.
37. Ashida K, Momiyama Y, Fayad ZA, Tanaka N, Kato R, Taniguchi H, Ohmori R, Kihara T, Kameyama A, Nagata M, et al.: Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosis. J Cardiovasc Magn Reson 2007, 9:855-861. (Pubitemid 350232926)
38. Momiyama Y, Fayad ZA: Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging 2007, 18:349-355. (Pubitemid 350145115)
39. Yonemura A, Momiyama Y, Fayad ZA, Ayaori M, Ohmori R, Higashi K, Kihara T, Sawada S, Iwamoto N, Ogura M, et al.: Effect of lipidlowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 2005, 45:733-742. (Pubitemid 40278972)
40. El Aidi H, Mani V, Weinshelbaum KB, Aguiar SH, Taniguchi H, Postley JE, Samber DD, Cohen EI, Stern J, Geest RJ van der, et al.: Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med 2009, 6:219-228.
41. Woodward M: Epidemiology: Study Design and Data Analysis Second edition. Boca Raton: Chapman and Hall/CRC Press; 2005.
42. Yuan C, Beach KW, Smith LH Jr, Hatsukami TS: Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998, 98:2666-2671. (Pubitemid 28564000)